4//SEC Filing
OBrien Christopher Flint 4
Accession 0001209191-17-055457
CIK 0000914475other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 7:14 PM ET
Size
9.2 KB
Accession
0001209191-17-055457
Insider Transaction Report
Form 4
OBrien Christopher Flint
Sr. VP & Chief Medical Officer
Transactions
- Exercise/Conversion
Non-Qualified Stock Option
2017-10-02$8.65/sh−6,925$59,901→ 70,341 totalExercise: $8.65Exp: 2023-01-10→ Common Stock (6,925 underlying) - Sale
Common Stock
2017-10-02$61.04/sh−6,925$422,702→ 48,973 total - Exercise/Conversion
Common Stock
2017-10-02$8.65/sh+6,925$59,901→ 55,898 total
Footnotes (3)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.93. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Option granted January 10, 2013 and vested over 4 years.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001343124
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 7:14 PM ET
- Size
- 9.2 KB